Ernexa Therapeutics Inc. Defined Contribution Plan, Employer Matching Contribution, Percent of Match
Ernexa Therapeutics Inc. (ERNA) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Match of 50.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch · last filed 2021-03-11
- Ernexa Therapeutics Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2020 was 50.00%, a 0.00% change from fiscal 2019.
- Ernexa Therapeutics Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2019 was 50.00%, a 0.00% change from fiscal 2018.
- Ernexa Therapeutics Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2018 was 50.00%.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 12 month |
|---|---|
| 2020-12-31 | 50.00% 10-K · filed 2021-03-11 |
| 2019-12-31 | 50.00% 10-K · filed 2020-03-19 |
| 2018-12-31 | 50.00% 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |